Both in Surgical Instruments
MiMedx Group vs Cerus
Over the past year MDXG returned −56.8% and CERS returned +53.9%; their daily moves had a correlation of 0.25.
MDXG −56.8% CERS +53.9%Growth of $1, one year, split-adjusted
| Metric | MDXG | CERS |
|---|---|---|
| Price | $3.25 | $2.34 |
| Market cap | $474.3M | $471.6M |
| Today | −0.91% | −0.85% |
| 1 month | −28.6% | 0.0% |
| 6 months | −10.7% | −9.7% |
| Year to date | −52.0% | +13.6% |
| 1 year | −57.5% | +59.2% |
| Revenue growth (YoY) | −45.2% | +6.3% |
| Gross margin | 79.8% | 57.1% |
| Net margin | −13.9% | −0.9% |
| P/E (TTM) | — | — |
| Price / sales | 1.6× | 1.9× |
| Net cash | $120.8M | -$6.2M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 44.4% |
| Short % of float | 8.1% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).